Effects of Autogenic and Reciprocal Inhibition, Muscle Energy Techniques in the Management of Mechanical Neck Pain
1 other identifier
interventional
78
1 country
1
Brief Summary
Neck pain is among the most common musculoskeletal disorders worldwide and is an important public health issue in terms of personal wellbeing. Prevalence of neck pain show excessive variations, with a point prevalence varying between 6% and 22%, and one year prevalence ranging between 1.5-75%. Neck pain like all other mechanical disorders leads to pain, disability and decreased range of motion (ROM). Stretching is a very common exercise performed by sportsmen, elderly, in physical therapy and rehabilitation patients, thus practiced in all sorts of fitness programs. The major types of stretching included in the literature are static, dynamic and pre-contraction stretching; of which static stretching is the conventional type of stretching. The different types of pre-contraction stretching include Proprioceptive Neuromuscular Facilitation (PNF) stretching, Post Isometric Relaxation (PIR), Post Facilitation stretch (PFS) and Active Isolated Stretch (AIS). Pre-contraction stretching is also considered a part of Muscle Energy Technique (MET). Recently MET and pre-contraction stretching have been shown to have significant superiority over conventional stretching in management of mechanical neck pain, but the evidence is currently lacking regarding which of the two pre-contraction stretching protocols, namely autogenic and reciprocal inhibition is more effective than the other. A RCT will be conducted in order to find and compare the effectiveness of conventional stretching and pre-contraction stretching (autogenic inhibition and reciprocal inhibition). One Control group (conventional group) and two Experimental groups (Experimental Group A - Autogenic Inhibition \& Experimental Group B - Reciprocal Inhibition) will be formed. The participants will be recruited in the study if they meet the inclusion criteria using consecutive sampling from Fauji Foundation Hospital and randomized into the three respective groups. All the groups will receive the gold standard treatment for chronic neck pain including mobilization and modalities. In addition to the gold standard treatment the participants will receive specific stretching protocol based on their interventional group
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2017
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 10, 2017
CompletedStudy Start
First participant enrolled
April 11, 2017
CompletedFirst Posted
Study publicly available on registry
May 2, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2017
CompletedFebruary 8, 2018
December 1, 2017
8 months
April 10, 2017
February 7, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Pain (Numeric Pain Rating Scale) - Change is being assessed
To measure the pre and post patient's perception of pain
Pre-treatment (First day before treatment), Immediate Follow Up (After 1st treatment session) & Follow Up (After 5 days of Treatment)
Cervical Range of Motion (CROM) - Change is being assessed
To measure patient's improvement in cervical range of motion
Pre-treatment (First day before treatment), Immediate Follow Up (After 1st treatment session) & Follow Up (After 5 days of Treatment)
Neck Disability Index (NDI) - Change is being assessed
to measure patient's pre and post functional disability
Pre-treatment (First day before treatment), Immediate Follow Up (After 1st treatment session) & Follow Up (After 5 days of Treatment)
Cervical Isometric Muscle Strength (Modified Sphygmomanometer dynamometry) - Change is being assessed
To measure patient's improvement in Isometric Muscle Strength
Pre-treatment (First day before treatment), Immediate Follow Up (After 1st treatment session) & Follow Up (After 5 days of Treatment)
Study Arms (3)
Group A (Control Group - Static Stretching)
ACTIVE COMPARATOR(Control Group - Static Stretching + Standard Treatment)
Group B (Autogenic Inhibition MET)
EXPERIMENTAL(Autogenic Inhibition - PIR + Standard treatment)
Group C (Reciprocal Inhibition MET)
EXPERIMENTAL(Reciprocal Inhibition - RI + Standard treatment)
Interventions
o Conventional Gold Standard treatment (Manual Therapy + Modalities) Conventional Static Stretching 15-30 seconds hold 3-5 repetitions (Page P, 2012) for Ant/Middle/Posterior Scaleni, Sternocleidomastoid, Levator Scapulae and Upper Trapezius Muscles.
o Conventional Gold Standard treatment (Manual Therapy + Modalities) Post Isometric Relaxation MET (3-5 reps) for Ant/Middle/Posterior Scaleni, Sternocleidomastoid, Levator Scapulae and Upper Trapezius Muscles. (Chaitow L, 2006)
o Conventional Gold Standard treatment (Manual Therapy + Modalities) Reciprocal Inhibition MET (3-5 reps) for Ant/Middle/Posterior Scaleni, Sternocleidomastoid,Levator Scapulae and Upper Trapezius Muscles (Chaitow L, 2006)
Eligibility Criteria
You may qualify if:
- Age 18 to 70 years;
- Neck pain on NPRS 4 to 8 (moderate cases);
- Subacute or chronic cases (4 to 12 weeks).
- Decreased or painful Cervical range of motion (CROM)
You may not qualify if:
- Signs of serious pathology (e.g., malignancy, inflammatory disorder, infection);
- History of cervical spine surgery in previous 12 months;
- History of trauma or fractures in cervical spine;
- Signs of cervical radiculopathy or myelopathy; and
- Vascular syndromes such as VBI
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Foundation University Institute of Rehabilitation Sciences
Islamabad, Pakistan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Muhammad Osama, DPT, MS-OMPT, CHPE
Foundation University Islamabad
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- The participant, investigator and outcome assessor are not aware of which treatment group the participant/patient is placed in.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 10, 2017
First Posted
May 2, 2017
Study Start
April 11, 2017
Primary Completion
November 30, 2017
Study Completion
December 30, 2017
Last Updated
February 8, 2018
Record last verified: 2017-12
Data Sharing
- IPD Sharing
- Will not share